MIA2
(Melanoma Inhibitory Activity Protein 2 (MIA2))
Protein Region
Middle Region
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-CTAGE5 antibody (Catalog #: ARP40618_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
MIA2
(Melanoma Inhibitory Activity Protein 2 (MIA2))
Synonymes
MEA6 Peptide, MGEA Peptide, MGEA11 Peptide, MGEA6 Peptide, zgc:56047 Peptide, melanoma inhibitory activity 2 Peptide, CTAGE family, member 5 Peptide, CTAGE family member 5, ER export factor Peptide, MIA2 Peptide, ctage5 Peptide, CTAGE5 Peptide, Mia2 Peptide
Sujet
CTAGE5 belongs to the cTAGE family. It functions as tumor-associated antigen. This autoantigen found in several cancer types, including benign meningioma and cutaneous T-cell lymphoma (CTCL).